What Does the CONVERT Trial Really Tell Us About Conversion From Calcineurin Inhibitors to Sirolimus?

被引：3

作者：

Hanto, Douglas W. ^{[1
,2
]}

Chudzinski, Robyn ^{[1
,2
]}

机构：

[1] Beth Israel Deaconess Med Ctr, Transplant Inst, Boston, MA 02215 USA

[2] Harvard Univ, Sch Med, Dept Surg, Div Transplantat, Boston, MA 02115 USA

来源：

TRANSPLANTATION | 2009年 / 87卷 / 02期

关键词：

TRANSPLANTATION; SURVIVAL;

D O I：

10.1097/TP.0b013e318192790f

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：164 / 165

页数：2

共 6 条

[1] Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination [J].

Gonwa, TA ;

Hricik, DE ;

Brinker, K ;

Grinyo, JM ;

Schena, FP .

TRANSPLANTATION, 2002, 74 (11) :1560-1567

[2] Improved graft survival after renal transplantation in the United States, 1988 to 1996. [J].

Hariharan, S ;

Johnson, CP ;

Bresnahan, BA ;

Taranto, SE ;

McIntosh, MJ ;

Stablein, D .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (09) :605-612

[3] The evolving role of alemtuzumab (Campath-1H) for immunosuppressive therapy in organ transplantation [J].

Magliocca, Joseph F. ;

Knechtle, Stuart J. .

TRANSPLANT INTERNATIONAL, 2006, 19 (09) :705-714

[4]

Meier-Kriesche HU, 2004, AM J TRANSPLANT, V4, P1289, DOI 10.1111/j.1600-6143.2004.00515.x

[5] Chronic allograft nephropathy: current concepts and future directions [J].

Nankivell, BJ ;

Chapman, JR .

TRANSPLANTATION, 2006, 81 (05) :643-654

[6] Conversion From Calcineurin Inhibitors to Sirolimus Maintenance Therapy in Renal Allograft Recipients: 24-Month Efficacy and Safety Results From the CONVERT Trial [J].

Schena, Francesco P. ;

Pascoe, Michael D. ;

Alberu, Josefina ;

del Carmen Rial, Maria ;

Oberbauer, Rainer ;

Brennan, Daniel C. ;

Campistol, Josep M. ;

Racusen, Lorraine ;

Polinsky, Martin S. ;

Goldberg-Alberts, Robert ;

Li, Huihua ;

Scarola, Joseph ;

Neylan, John F. .

TRANSPLANTATION, 2009, 87 (02) :233-242

← 1 →